Mir-184 post-transcriptionally regulates SOX7 expression and promotes cell proliferation in human hepatocellular carcinoma

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Wu, Geng Gang ^a   Li, Wen Hong ^a   He, Wen Guang ^a   Jiang, Nan ^a   Zhang, Guang Xian ^b   Chen, Wei ^c   Yang, Hai Feng ^b   Liu, Qi Long ^a   Huang, Yan Nian ^a   Zhang, Lei ^a   Zhang, Tong ^a   Zeng, Xian Cheng ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b GUANGZHOU UNIVERSITY OF CHINESE MEDICINE   (China)

^c THE SECOND AFFILIATED HOSPITAL OF ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MICRORNA; MICRORNA 184; MYC PROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR SOX7; UNCLASSIFIED DRUG; MESSENGER RNA; MIRN184 MICRORNA, HUMAN; SOX7 PROTEIN, HUMAN; TRANSCRIPTION FACTOR SOX;

ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER STAGING; CANCER TISSUE; CARCINOGENICITY; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; TRANSCRIPTION REGULATION; UPREGULATION; CARCINOGENESIS; CELL CYCLE; GENETICS; LIVER TUMOR; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE;

BASE SEQUENCE; CARCINOGENESIS; CARCINOMA, HEPATOCELLULAR; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; MICRORNAS; RNA, MESSENGER; SOXF TRANSCRIPTION FACTORS;

EID: 84895880911     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0088796     Document Type: Article

References (36)

1. Willatt JM, Francis IR, Novelli PM, Vellody R, Pandya A, et al. (2012) Interventional therapies for hepatocellular carcinoma. Cancer Imaging 12: 79-88.
2. Jemal A, Bray F, Center MM, Ferlay J, Ward E, et al. (2011) Global cancer statistics. CA Cancer J Clin 61: 69-90.
3. Lei J, Yan L (2012) Comparison between living donor liver transplantation recipients who met the Milan and UCSF criteria after successful downstaging therapies. J Gastrointest Surg 16: 2120-2125.
4. Takayama T (2011) Surgical treatment for hepatocellular carcinoma. Jpn J Clin Oncol 41: 447-454.
5. Ambros V (2004) The functions of animal microRNAs. Nature 431: 350-355.
6. Bartel DP (2004) MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116: 281-297.
7. Jiang L, Lin C, Song L, Wu J, Chen B, et al. (2012) MicroRNA-30e* promotes human glioma cell invasiveness in an orthotopic xenotransplantation model by disrupting the NF-kappaB/IkappaBalpha negative feedback loop. J Clin Invest 122: 33-47.
8. Hagan JP,Croce CM (2007) MicroRNAs in carcinogenesis. Cytogenet Genome Res 118: 252-259. (Pubitemid 350125264)
9. Calin GA, Croce CM (2006) MicroRNA signatures in human cancers. Nat Rev Cancer 6: 857-866. (Pubitemid 44629897)
10. Farazi TA, Hoell JI, Morozov P, Tuschl T (2013) MicroRNAs in human cancer. Adv Exp Med Biol 774: 1-20.
11. Kusenda B, Mraz M, Mayer J, Pospisilova S (2006) MicroRNA biogenesis, functionality and cancer relevance. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150: 205-215.
12. Markou A, Liang Y, Lianidou E (2011) Prognostic, therapeutic and diagnostic potential of microRNAs in non-small cell lung cancer. Clin Chem Lab Med 49: 1591-1603.
13. Cho WC (2007) OncomiRs: the discovery and progress of microRNAs in cancers. Mol Cancer 6: 60.
14. Gandillet A, Serrano AG, Pearson S, Lie ALM, Lacaud G, et al. (2009) Sox7-sustained expression alters the balance between proliferation and differentiation of hematopoietic progenitors at the onset of blood specification. Blood 114: 4813-4822.
15. Cermenati S, Moleri S, Cimbro S, Corti P, Del Giacco L, et al. (2008) Sox18 and Sox7 play redundant roles in vascular development. Blood, 111: 2657-2666.
16. Francois M, Koopman P, Beltrame M (2010) SoxF genes: Key players in the development of the cardio-vascular system. Int J Biochem Cell Biol 42: 445-448.
17. Seguin CA, Draper JS, Nagy A, Rossant J (2008) Establishment of endoderm progenitors by SOX transcription factor expression in human embryonic stem cells. Cell Stem Cell 3: 182-195.
18. Savage J, Conley AJ, Blais A, Skerjanc IS (2009) SOX15 and SOX7 differentially regulate the myogenic program in P19 cells. Stem Cells 27: 1231-1243.
19. Hayano T, Garg M, Yin D, Sudo M, Kawamata N, et al. (2013) SOX7 is down-regulated in lung cancer. J Exp Clin Cancer Res 32: 17.
20. Li B, Ge Z, Song S, Zhang S, Yan H, et al. (2012) Decreased expression of SOX7 is correlated with poor prognosis in lung adenocarcinoma patients. Pathol Oncol Res 18: 1039-1045.
21. Chan DW, Mak CS, Leung TH, Chan KK, Ngan HY (2012) Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer. Oncotarget 3: 1546-1556.
22. Zhang Y, Huang S, Dong W, Li L, Feng Y, et al. (2009) SOX7, down-regulated in colorectal cancer, induces apoptosis and inhibits proliferation of colorectal cancer cells. Cancer Lett 277: 29-37.
23. Guo L, Zhong D, Lau S, Liu X, Dong XY, et al. (2008) Sox7 Is an independent checkpoint for beta-catenin function in prostate and colon epithelial cells. Mol Cancer Res 6: 1421-1430.
24. Katoh M (2002) Expression of human SOX7 in normal tissues and tumors. Int J Mol Med 9: 363-368.
25. Hahn WC, Dessain SK, Brooks MW, King JE, Elenbaas B, et al. (2002) Enumeration of the simian virus 40 early region elements necessary for human cell transformation. Mol Cell Biol 22: 2111-2123. (Pubitemid 34224619)
26. Li J, Zhang N, Song LB, Liao WT, Jiang LL, et al. (2008) Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival. Clin Cancer Res 14: 3319-3326.
27. Kormish JD, Sinner D, Zorn AM (2010) Interactions between SOX factors and Wnt/beta-catenin signaling in development and disease. Dev Dyn 239: 56-68.
28. Takash W, Canizares J, Bonneaud N, Poulat F, Mattei MG, et al. (2001) SOX7 transcription factor: sequence, chromosomal localisation, expression, transactivation and interference with Wnt signalling. Nucleic Acids Res 29: 4274-4283. (Pubitemid 33064768)
29. Esquela-Kerscher A, Slack FJ (2006) Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269.
30. Walter BA, Valera VA, Pinto PA, Merino MJ (2013) Comprehensive microRNA Profiling of Prostate Cancer. J Cancer 4: 350-357.
31. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, et al. (2008) Mature miR-184 as Potential Oncogenic microRNA of Squamous Cell Carcinoma of Tongue. Clin Cancer Res 14: 2588-2592.
32. Xu Y, Ma H, Yu H, Liu Z, Wang LE, et al. (2013) The miR-184 binding-site rs8126 T.C polymorphism in TNFAIP2 is associated with risk of gastric cancer. PLoS One 8: e64973.
33. Foley NH, Bray IM, Tivnan A, Bryan K, Murphy DM, et al. (2010) MicroRNA-184 inhibits neuroblastoma cell survival through targeting the serine/threonine kinase AKT2. Mol Cancer 9: 83.
34. Tivnan A, Foley NH, Tracey L, Davidoff AM, Stallings RL (2010) MicroRNA-184-mediated inhibition of tumour growth in an orthotopic murine model of neuroblastoma. Anticancer Res 30: 4391-4395.
35. Gao B, Gao K, Li L, Huang Z, Lin L (2013) miR-184 functions as an oncogenic regulator in hepatocellular carcinoma (HCC) Biomed Pharmacother. In press.
36. Katoh Y, Katoh M (2005) Comparative genomics on SOX2 orthologs. Oncol Rep 14: 797-800.